Asher Barzilai

Medicine & Life Sciences

1. Child 100%
2. Premature Infants 71%
3. Anti-Bacterial Agents 65%
4. Infections 63%
5. HIV 60%
6. Pefloxacin 54%
7. Ciprofloxacin 48%
8. Streptococcus 42%
9. Otitis Media 39%
10. Newborn Infant 39%
11. Therapeutics 38%
12. Neonatal Intensive Care Units 38%
13. Mothers 37%
14. Bacteremia 36%
15. Disease Outbreaks 35%
16. Middle Ear 32%
17. Streptococcus pyogenes 32%
18. Pediatrics 31%
19. Chickenpox 30%
20. Methicillin-Resistant Staphylococcus aureus 29%
21. Visual Evoked Potentials 28%
22. Neonatal Screening 27%
23. Fever 27%
24. Parturition 26%
25. Intravenous Immunoglobulins 26%
26. Adult Respiratory Distress Syndrome 25%
27. Antibodies 25%
28. Human Influenza 24%
29. Cytomegalovirus 23%
30. Epithelial Cells 23%
31. Alice in Wonderland Syndrome 22%
32. Communicable Diseases 21%
33. Cultured Cells 21%
34. Human Herpesvirus 3 21%
35. Pediatric Intensive Care Units 21%
36. Israel 21%
37. Pharynx 21%
38. Virus Diseases 21%
39. Hepatitis B 21%
40. Bone Marrow 21%
41. Ventilation 20%
42. Otoscopes 20%
43. Hepatitis A Antibodies 20%
44. Candidemia 20%
45. Anonymous Testing 20%
46. Hepatitis B Vaccines 20%
47. Hemophilia A 20%
48. Vaccination 19%
49. Agar 19%
50. Burkholderia cenocepacia 19%